Study Re-Examines Bacterial Vaccine Studies Conducted During 1918 Influenza Pandemic
Secondary infections with bacteria such as Streptococcus pneumoniae, which causes pneumonia, were a major cause of death during the 1918 flu pandemic and may be important in modern pandemics as well, according to a new article in the Journal of Infectious Diseases co-authored by David M. Morens, MD, senior advisor to the director of the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
The researchers examined 13 studies published between 1918 and 1920. During this time, many scientists erroneously believed that influenza was caused by bacteria, not a virus. As a result, researchers began performing and publishing results from clinical trials testing bacterial vaccines designed to prevent the flu. In their new study, Morens and his colleagues used modern statistical and evaluation methods to re-analyze the vaccine effectiveness data from these old studies in an attempt to correct for any statistical biases in the original analysis.
In addition to confirming the importance of bacterial infections associated with the 1918 influenza pandemic, the new analysis suggests that the use of bacterial vaccines containing S. pneumoniae could reduce pneumonia rates and deaths in modern influenza pandemics as well. During the 2009-2010 H1N1 influenza pandemic, the authors write, autopsy results implicated bacterial infections in 29 to 55 percent of deaths. In light of this study, the authors recommend more research into the use of bacterial vaccines to prevent illness and death associated with influenza.
Reference: Y-W Chien et al. Efficacy of bacterial vaccines in preventing pneumonia and death during the 1918 influenza pandemic. Journal of Infectious Diseases. DOI: 10.1086/657144 (2010).
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
From Pandemic to Endemic: How the Protective Face Mask Market Is Evolving
August 3rd 2025Once a symbol of crisis, face masks have evolved into everyday essentials—driven not only by pandemic preparedness but by rising air pollution, cultural shifts, and workplace safety regulations. As innovation and demand grow worldwide, the protective face mask market is poised for long-term expansion well beyond COVID-19.
Sharps Safety Starts with Us: Why Infection Preventionists Must Lead the Charge
August 3rd 2025Sharps injuries remain a silent but serious threat in health care that infection preventionists are uniquely equipped to confront. With underreporting widespread and safety devices underused, it’s time for IPs to step into a leadership role, using their expertise in systems thinking, education, and policy to build a culture where staff protection is as prioritized as patient care.
The Green Revolution in SPD: From Hidden Cost to Frontline Change
August 3rd 2025As climate change accelerates, health care’s environmental impact faces increased scrutiny, with sterile processing departments (SPDs) emerging as key change agents. Often behind the scenes, SPD professionals can lead sustainability by turning routine practices into ecofriendly protocols that protect both patient and planetary health.
